Venture Capital

With a new chip using just 34 microwatts, POLYN's analog AI promises a future of truly always-on voice control without sacrificing battery or privacy.

A female-founded climate-tech startup brings its patented, 90% effective mosquito-trapping technology from luxury resorts to your backyard via Amazon.

Tebra's new $250M funding aims to level the playing field for private practices with AI tools that automate tasks and boost profitability.

Dartmouth Cancer Center gains a top designation for using GammaTile, an innovative implant that delivers immediate radiation during brain tumor surgery.

Amid a booming uranium market, Stallion Uranium has increased its private placement to over $6M, signaling strong investor confidence in Athabasca Basin exploration.

Backed by Google, a massive AI data center lease transforms Hut 8 and promises a generational economic windfall for Louisiana in the AI arms race.

A Chinese dance drama fusing martial arts and contemporary dance earns global acclaim, bridging cultural divides from Shenzhen to its sold-out Toronto debut.

A new once-monthly, self-injected cholesterol drug gets FDA nod, offering more convenience and setting the stage for a major market push in China.

SCALE AI's record funding fuels 44 new projects, aiming to accelerate homegrown AI and secure Canada's digital future amid fierce global competition.

A leading flavor firm predicts our next culinary obsession. Discover why dark sweet cherry, from nostalgic roots to social media fame, is set to dominate 2026.

Startup Nauta unveils an AI engine to predict supply chain disruptions, promising to save millions by preventing costly holiday stockouts. Here's how.

New data shows Vyriad's VV169 eliminated myeloma in mice without severe toxicity, signaling a potential shift to safer, scalable 'off-the-shelf' CAR T.

An exclusive Miami summit gathers top investors and CEOs to heed a stark warning: embrace the AI disruption or face extinction. What will they decide?

New platform integrates medical records, labs, and wearables, turning overwhelming data into personalized health protocols. Is this the future of accessible care?

A Texas optometrist launches a new supplement aiming to fight dry eye and glare from the inside out. Can this clean-label formula change eye care?

Digital ad company Viewbix is acquiring Quantum X Labs, a deep-tech firm with a key patent in quantum error correction. Is this a visionary leap or a risky gamble?

After bombshell allegations and a stock plunge, Rezolve AI faces a major lawsuit investigation, raising critical questions about AI hype and corporate honesty.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

A Chinese startup's tiny new heart pump enters human trials, aiming to disrupt a billion-dollar market and solve a massive unmet need in cardiac care.

Beyond a routine board re-election, Heidmar Maritime is doubling down on an AI-driven strategy to navigate the volatile tanker market. Here's what it means.